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Serum  complement  has  traditionally been  defined  as  a  four  component 
system, Cq, C'2, C~3,  and C~4. Although several investigators had suggested the 
existence of additional components (for review of earlier literature, see refer- 
ence 1), only recently has unequivocal evidence been available supporting the 
further  complexity of  complement.  The  third  component,  C'3,  was  shown 
first to consist of at least two activities (1--4) and then three (5, 6), designated 
C~3a, C'3b, and C'3c. A highly purified protein,/31o-globulin  (7), would appear 
to be identical with C'3a (5). 
Miiller-Eberhard  and  Kunkel  (8,  9)  and  Taranta,  Weiss,  and  Franklin 
(10)  have  described  a  new serum  protein,  distinct from the  classical  com- 
ponents of complement and designated the llS component on the basis of its 
sedimentation constant. In earlier work on the sequence of action of the com- 
ponents of complement (11,  12), the first component, C'I, was the first factor 
recognized  to  interact  with  sensitized  erythrocytes. However,  evidence has 
been presented that the I1S component participates in immune hemolysis at 
a  stage even earlier than  Ctl  (8,  9),  an observation which would appear to 
require revision of previous concepts of sequence. 
It is  the purpose of this paper to report  the resolution of Cq  into three 
activities  by  chromatography on  diethylaminoethyl (DEAE)  cellulose  of a 
euglobulin fraction of normal human serum.  It will be shown that all three 
factors are  required  for reconstitution of  Cq  activity in  several  hemolytic 
systems and for generation of Cq esterase in the absence of antigen-antibody 
complexes (13).  Data will be presented supporting the identity of one of these 
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factors with the  11S  component  (8-10)  and  another  with  CPl  proesterase,  the 
proenzyme  associated  with  Crl  and  capable  of activation  to  C'1  esterase  (14, 
15).  The  third  factor,  previously  unrecognized,  represents  a  new  component 
of  complement.  The  three  factors,  eluted  from DEAE  cellulose in  the  order 
(a) 11S component,  (b) new component, and (c) C'1 proesterase, are tentatively 
designated  CPlq,  C'lr,  and  C'ls,  respectively.  In  view  of  these  findings,  the 
11S component may be considered as one part of the activity originally ascribed 
to CPl, an interpretation  which requires revision of detail but not of substance 
of previous investigations on the earliest steps  of complement  action  (11,  12). 
Materials and Methods 
Human Serum.--ttuman blood collected without anticoagulant was allowed to clot at room 
temperature for several hours and was stored at  I°C overnight for maximal clot retraction. 
The serum was separated by centrifugation at  I°C. Pools of serum from  10  to  100  donors 
were frozen in  aliquots  at  -70°C. 
Guinea Pig Serum.--Guinea pig blood was obtained by cardiac puncture  and  the serum 
separated and stored as described for human serum. 
Salts  of  Ethylenediaminetetraaceti¢ Acid  (EDTA).--Reagent  grade  Na2H2EDTA  was 
titrated  to pH 7.4 at a stock concentration of 0.15  •,  giving a  solution largely in the form 
Na3HEDTA.  Na2MgEDTA  (Geigy Chemical Corp.,  Ardsley,  New York)  was  titrated  to 
pH 7.4 at a stock concentration of 0.15 ~. 
Buffer  Diluents for  Complement Assays.--Triethanolamine-buffered  saline  (TBS)  at  pH 
7.4, ionic strength 0.15, containing 1.5 X  10  -4 ~  Ca  ++ and 5 X  10  -4 ~ Mg  ++ (16), was employed 
as the diluent in all assays involving a hemolytic system other than the Donath-Landsteiner 
reaction. In the latter case, barbital buffer of comparable constitution was used (12). TBS-gela- 
tin buffer was prepared by making a final concentration of 0.05 per cent gelatin (Knox special 
intravenous,  Knox Gelatine Protein  Products,  Inc.,  Camden,  New Jersey)  in TBS buffer. 
TBS-gelatin-Na3HEDTA buffer contained 8  X  10-~M  Na3HEDTA.  TBS-gelatin-Na2Mg- 
EDTA buffer contained 16 X  10"-* ~  Na~MgEDTA. 
Soy  Bean  Trypsin  Inhibitor.--The  five  times-recrystallized  inhibitor  (Nutritional  Bio- 
chemicals Corporation, Cleveland) was suspended in TBS buffer at a concentration of 15 mg 
per ml or weighed and transferred to reaction vessels for suspension in the reactants. 
Sensitized Sheep Erythrocytes (EA).--Sterile sheep erythrocytes in Alsever's solution were 
washed, standardized spectrophotoraetrically to a concentration of 109 per ml, and sensitized 
with an equal volume of an appropriate dilution of rabbit hemolysin. Two types of hemolysin 
were  used:  glycerinated  anti--sheep  erythrocyte  rabbit  serum  (Cappel  Laboratories,  West 
Chester, Pennsylvania); and anti-Forssman serum prepared by immunization of rabbits with 
boiled sheep erythrocyte stromata  (in  part,  kindly supplied by Dr. M. M.  Mayer).  When 
using commercial antiserum,  sensitization was performed with 4  units of hemolysin, as de- 
termined by the method described in Kabat and Mayer  (17).  In the case of anti-Forssman 
rabbit  serum,  optimal sensitization was achieved by the method  described by Mayer  (12). 
Since glycerinated hemolysin contains  variable  amounts  of rabbit  C'I  not  inactivated  by 
heating at 56°C for 30 minutes (18), sensitization was performed in the presence of 8 X  10  -3 M 
Na3HEDTA, followed by three washes with TBS-gelatin buffer. C'I in the non-glycerinated 
anti-Forssman rabbit serum was inactivated by heating at 56°C for 30 minutes and the pres- 
ence  of  Na3HEDTA was, therefore, not necessary when the latter hemolysin was used for 
sensitization.  For reasons  to  be discussed  below,  suspensions  of EA prepared  with  heated 
anti-Forssman rabbit serum were washed twice with equal volumes of TBS-gelatin buffer. LEPOW,  NA~F, TODD, PENSTCy,  AND HINZ~ JR.  985 
Human  Complement Reagents.--The four well recognized components of complement are 
indicated by the symbols C'I, C'2, C'3, and C'4. Serum fractions or reagents which are defi- 
cient in one of these components are designated R1, R2, R3, and R4, respectively, and were 
prepared essentially as described by Mayer (12) with modifications summarized by Wedgwood 
(19).  The  llS  component  and  the  serum  reagent  deficient in  llS  component,  designated 
RllS, were prepared according to the procedures of Mtiller-Eberhard and Kunkel (8), modi- 
fied  as follows: (a)  in the preparation  of aggregated T-globulin, one-tenth volume of pI-I 8 
sodium phosphate buffer,  ionic strength 0.15,  was added to 0.15 M NaC1;  (b)  the aggregated 
T-globulin was used at a concentration of 20 O.D. units/ml (280 m/,); one-fifth volume rela- 
tive to serum was added in preparation of llS component, whereas an equal volume was added 
to make RIlS;  (c)  Spinco ultracentrffugation was in a  No. 40 rotor at 40,000  Rwr for 60 
minutes in the preparation of llS component, and  120 minutes in the preparation of RllS. 
Complexes between Complement and Sensitized Skeep Erytkracytes.-- 
EA-huCtl, 4, ~. This intermediate complex between human  complement and  EA having 
the  activities of C'I, C'4,  and  C'2 was prepared  with human  R3  according to Leon  (20). 
The activity of this complex can be quantified by measuring the extent of hemolysis by human 
serum in the presence  of 8  X  10  --s ~  NasHEDTA. Na3HEDTA chelates  Ca  ++ and  Mg  ++, 
blocking the action of Cq, C'4, and C'2 but permitting reaction of CJ3 (21). 
EA-huC'I,  4. This intermediate complex between human complement and EA having the 
activities of C'I and C J4 was prepared by inactivating the C~2 activity of washed EA-huC~x, t. s 
at 37°C for 40 minutes  (22). The activity of this complex can be quantified by measuring the 
extent of hemolysis by human serum containing Na~MgEDTA. NasMgEDTA chelates Ca  ++ 
but not  Mg  ++ and therefore permits C~2 and C~3 to function while blocking the activity of 
C'I (21). For consistent results, a concentration of 16 X  10  "sm NazMgEDTA was necessary. 
EA-huC~4. This intermediate complex between human  complement and  EA having the 
activity of C~4 was prepared by ehiting C~I from EA-huC'I. 4 (23, 24).  The elution was per- 
formed twice with 5  X  10  "4 ~  NasHEDTA in TBS-gelatin buffer at 37°C for 15 minutes, 
using 10 ml of Na3HEDTA with the pellet from 100 ml of the complex EA-huC'I, 4. This 
complex, which will not hemolyze in the presence of human serum containing 16  X  10  -s 
Na2MgEDTA, may be employed for detection of C'I. Incubation  of a  solution containing 
C'I with EA-huCt4 will result in formation of the complex EA-huCtl, 4 which can be measured 
as indicated above. In this situation, the extent of hemolysis of EA-huCJx, 4 by human serum 
containing 16  X  10  -'s M Na2MgEDTA is a  measure of the C~I activity of the original test 
solution. 
EA-I,  uC~I. This intermediate complex between human  complement and  EA having the 
activity of C~I was prepared  by direct reaction of EA with a  source of C~I deficient in Ct4 
(23, 25-27). The activity of this complex can be quantified by measuring the extent of hemol- 
ysis  either  by R1 or by human  serum containing 16 X  10  -s x, Na2MgEDTA. R1 contains 
C~2, C'3, and C~4 but is deficient in C~I while NasMgEDTA chelates Ca++, blocking further 
action of C~I, but permitting reaction of C'2, CJ3, and C'4. 
Measurement of Components of Complement.--The  components C~1, C~2, Cr3, and Ct4 were 
estimated in indicated instances by serial dilution of samples and measurement of the extent 
of hemolysis when added  to EA in the presence of R1, R2, R3, and R4, respectively (12). 
The actual methods used and the definition of units have been given in detail elsewhere (13, 
28).  C~I was also measured by its abifity to form the complex EA-huC~I, 4 from EA-huC'4, 
and to form directly the complex EA-huC~x. C'4 in partially purified preparations was esti- 
mated by the serial dilution method, using R4 fortified with a source of C~3a. C~3a was meas- 
ured by the amount of hemolysis obtained when the complex EA-huCtL 4, s was incubated 
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taining 8 X  10  -8 ~ Na3HEDTA (29). 11S Component  was assayed by its ability to reconstitute 
the hemolytic activity of RllS. One unit of 11S component activity was defined as the least 
volume of test fraction capable of causing 50 per cent hemolysis of 1.0 ml of EA (2.5  X  108) 
in the presence of 0.08 to 0.10 ml of RlIS during incubation at 37°C for 30 minutes. The 
preparation of 11S component used in the experiments to be described contained 60 units/ml. 
All assays involving intermediate complexes were performed in baths controlled to -*-0.1°C, 
using a wrist-action shaker for mixing. The final lyric reaction in these cases was performed 
at 32°C for 60 minutes and the extent of hemolysis measured by reading the optical density 
at 541  m/z of the supernatant solution. 
Donath-Laruisteiner Reaction.--The Donath-Landsteiner reaction,  an immune  hemolytic 
system entirely of human origin, has provided a convenient model for study of the mechanism 
of  action of human complement.  The antibody is contained in serum from patients with 
paroxysmal cold hemoglobinuria (PCH). The reaction is biphaslc in nature, requiring initially 
interaction of erythrocytes, antibody, and C'1 at 1°C. Hemolysis is completed after subsequent 
interaction with the remaining components of complement. 
The  reaction was  performed  as described previously  (30,  31).  The  Donath-Landsteiner 
antibodies used were contained in serum heated at 56°C for 30 minutes, or in fractions prepared 
chromatographically  (30).  Erythrocytes from  a  patient with paroxysmal  nocturnal  hemo- 
giobinuria  (PNH)  were used  throughout because of  their greater  sensitivity to  hemolytic 
antibodies. In the cold phase of the reaction, 0.05 ml of a  25 per cent suspension of  PNH 
erythrocytes, 0.05 to 0.10 ml of: antibody, 0.10 mi volumes of complement-containing frac- 
tions, and barbital buffer were incubated together in a volume of 0.35 to 0.50 ml at 1°C for 
30 minutes. The cells were washed twice at 1°C with barbital buffer, 0.30 ml of R1 was added, 
and the mixture was incubated at 37°C for 30 minutes. Hemolysis in the supernatant serum 
was measured at 541  m/~. 
Enzymatic Assay of C1 Esterase.--The esterolytic activity of C'l-esterase was measured 
using 5r-acetyl-L-tyrosine ethyl ester as substrate. One unit of C'1 esterase is defined as that 
amount which liberates 0.5 micromole of H + in 15 minutes at 37°C  as detected by micro- 
formol titration with 0.05 N NaOH (32, 33). 
Ion  Exchange Chromatography.--Diethylaminoethyl (DEAE)  cellulose,  (high  capacity, 
type 20, exchange capacity 1.05 meq/gm, Carl Schleicher and Schiiil Co., Keene, New Hamp- 
shire) was suspended in 30 times its weight of water, stirred vigorously, and allowed to settle 
for several hours.  The supematant  fluid, containing fine particles,  was  decanted,  and  the 
washing was repeated until the supernatant fluid was completely clear after 30 minutes of 
settling. Washing was continued on a  coarse sintered-glass funnel with a  solution containing 
0.125  ~  NaOH  and 0.125 m NaC1,  followed by water until washings were alkali-free. The 
washed adsorbent was suspended in starting buffer for packing into chromatographic tubes. 
The starting buffer in all cases was sodium phosphate, pH 7.4, ionic strength 0.15,  containing 
1  X  10  ~  ~t Na3HEDTA. t 
Columns were prepared from chromatography tubes (internal diameter 2.5 cm) by forcing 
a  magnetically stirred slurry of DEAE cellulose (10 to 20 gin/liter) into the tube under 5 
pounds per square inch air pressure until the packed  height of adsorbent was 25 cm. The 
column was transferred to a cold room (5°C), washed with several liters of cold starting buffer, 
and stored in starting buffer until used. 
After chromatography was completed, the DEAE cellulose was regenerated in the columns 
by flushing with 3 to 4 column volumes of a  solution containing 0.125 M NaOH and 0.125 ~r 
150 ml of 0.2 ~r NaH~PO4 was mixed with 233.5 ml of 0.2 ~  NasHPO4 and 6.67 mi of 0.15 
Na3HEDTA at pH 7.4. This solution was then diluted to 1000 mi with distilled water. LEPOW, NAF~F,  TODD, PENSKY~ AND HINZ, JR.  987 
NaC1, followed by 2 column volumes of 1 per cent (v/v) HC1, and starting buffer until the pH 
of the effluent was the same as the starting buffer. The use of dilute HC1 was found necessary 
for oniy every other chromatographic run with each column. Because of decreasing flow rates 
with successive use, it was found expedient to empty the columns after every 5 or 6 experi- 
ments and repack the tubes with fresh adsorbent. 
EXPERIMENTAL 
I.  Preparation and Properties  of a Euglobulin Fraction of Normal 
Human Serum Containing C'I Activity 
A.  Preparation of Euglobulin.--The preparation and properties of a partially 
purified fraction of human CI1 have been described previously (13, 14, 32). A 
simpler preparative procedure, yielding greater recovery of C'I but less initial 
purification, was devised for these investigations. The method is a modification 
of the procedure for preparing R2, the serum euglobulin fraction deficient in 
C'2, by dilution and acidification (12). 
One volume of human serum at  I°C  was added  with constant stirring to 8  volumes of 
acetate buffer, pH 5.5, ionic strength 0.02,  at 1°C.  The mixture was aLlowed to stand undis- 
turbed at 1°C overnight and the supernatant fluid was then withdrawn by siphon. The resid- 
ual precipitate was centrifuged at 4000 m,~t for 30 minutes at 1°C and washed at 1°C with a 
volume of acetate buffer, pit 5.5,  ionic strength 0.02, equal to the original volume of serum. 
The washed precipitate was suspended in 0.5 ~  NaC1 containing 10  -8 ~  Na3HEDTA  to one- 
tenth the original volume of serum and centrifuged  cold  at  30,000  avg  for 60  minutes in 
a  No. 30 rotor in the Spinco preparative ultracentrifuge. The superuatant  fluid was poured 
through a  filter of glass-wool to exclude particles of lipid and the filtrate  was  dialyzed at 
1°C ~s. 50 volumes of pH 7.4 phosphate buffer, ionic strength 0.15, containing 10  -ax¢ Na3- 
HEDTA. After 12 to 18 hours, the dialyzed fraction was centrifuged at 4000 ]~v~ for 30 min- 
utes at  1°C.  The resuiting opalescent solution, concentrated 10-fold  with respect to serum, 
represented the crude euglobulin fraction of C'1 employed as starting material for column 
chromatography. 
B.  Properties of Euglobulin Fraction as a Source of C1 in Hemolytic Systems.-- 
Yield and purification  of C'I:  Employing a  serial  dilution  assay with  R1 
and sensitized sheep erythrocytes (EA), 80 per cent of the Cq activity present 
in the original  serum was recovered in the euglobulin fraction.  The purifica- 
tion of C'I was 20-fold with respect to serum on the basis of nitrogen determi- 
nations,  and  16-fold on the basis of absorption at  280 m#.  Again employing 
serial  dilution  assays  with  R2,  R3,  or R4,  recoveries  of  other  components 
were: C'2,  <1 per cent;  C'3, 27 per cent; and  C'4, 2 per cent.  C'I  activity, 
measured as described above, was stable at  I°C,  -  20°C,  and  -60°C for at 
least 2 weeks.  This prolonged stability of C'I  at pH 7.4, ionic strength 0.15, 
was dependent upon the presence of Na3HEDTA, previously shown to inhibit 
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C'I activity as measured by formation  of the complex EA-huC'x,4: 
The complex EA-huC'~  may be prepared as shown schematically  in the following  reactions: 
EA  "4-  R3  Ca++' Mg++ ~  EA-huC'l.4.2 
37~C 
EA-huC'I.,.~  ,  EA-huC'L, 
NasI-IEDTA 
EA-huC'I,4  ~  EA-huC',  +  C'I eluate 
The resulting complex EA-huC% washed free of C'I eluate, is not hemolyzed 
by serum diluted  in Na2MgEDTA buffer but  is  hemolysed by R4.  If these 
criteria are met, the complex EA-huCt4 may be used for detection and measure- 
ment of C'I in unknown preparations.  For example: 
Ca  ++  EA-huC'4  +  euglobulin  ~  EA-huC'~,, 
Na~MgEDTA 
EA-huC'I,,  +  human  serum  ~  hemolysis 
Pellets of the complex EA-huC'4 containing 5  X  108  ceils  were  suspended 
in  1 ml of various  dilutions  of recalcified euglobulin.  The mixtures  were  in- 
cubated for 15 minutes at 37°C, washed with 5 ml of cold TBS-gelatin buffer, 
and suspended in 4 ml of human serum diluted 1/100 in Na2MgEDTA buffer. 
The extent of hemolysis was read at 541 mg after incubation at 32°C for 60 
minutes. 
The  euglobulin fraction of C•1  was highly active in  forming the  complex 
EA-huC'I,4 from the complex Ea-huC',. As  shown  in  Fig.  1,  the  extent  of 
formation of the complex EA-huCtl,4 was a sigmoidal function of the  relative 
concentration of C'1 supplied by the euglobulin. Less than  1 gg of nitrogen 
supplied sufficient C'I to yield EA-huC'I,4 complexes with significant hemolytic 
activity. 
C'1 Activity as measured by formation  of the complex EA-huC'I: The complex 
EA-huC'I may be prepared from sensitized sheep erythrocytes and a source of 
C'I: 
Ca  ++  EA  +  C'I  >  EA-huC'I 
The  resulting  complex may be  measured  by hemolysis  with  R1  or  human 
serum diluted in Na~MgEDTA buffer. 
Pellets of EA contMnlng 5 X  108 cells were suspended in 1 ml of various dilutions of re- 
calcified euglobulin. The mixtures were incubated for 10 minutes at 37°C. (In separate experi- 
ments it was found that EA-huC'I formation  was maximal at 37°C within several minutes and 
was not affected by further incubation for periods as long as 30 minutes.) Mter incubation the 
mixtures were centrifuged, washed with 5 ml of TBS-gelafin buffer at 37°C,  ~ and suspended 
2 It is critically important that the complex EA-huC'I be washed at an  elevated tempera- 
ture such as 37°C rather than in the cold. The authors are grateful to Dr. IVL A. Leon for this 
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in 4 ml of human serum diluted in Na2MgEDTA buffer.  The extent of hemolysis  was read at 
541 m/z after incubation  at 32°C for 60 minutes. 
The euglobulin fraction was highly active in forming the complex EA-huC'I. 
As shown in Fig.  1, the extent of formation of the complex  EA-huC'~ was  a 
sigmoidal function of the relative concentration of C'I supplied by the euglobu- 
lin.  The activity of the  euglobulin  in  forming  the  complex  EA-huC'I was 
approximately the same as that presented earlier for formation of EA-huC'a,4 
from EA-huC',. 
O.8 
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Dilullon  of Eu~loDUlln 
Fio. 1. C'I activity  of euglobulin  fraction  in forming intermediate  complexes: O, EA- 
huC'1,  4 from EA-huC~4;  A, EA-huC'I, using  normal eug]obulin  fraction;  ~, EA-huC'I, 
using  cuglobulin  fraction  prepared  from R4; ®, cold  phase of  the  Donath-Landsteiner reac- 
tion. 
This  experiment was  compromised  by the presence  of small  amounts of 
C'4 in the euglobulin fraction and the possibility that the complex formed, in 
fact, represented EA-huC'I.4. In order to demonstrate unequivocally that the 
euglobulin  fraction was capable  of forming EA-huC'I, the above experiment 
was repeated using a  euglobulin prepared from R4.  As shown in Fig.  1, this 
preparation, completely devoid of detectable C'4, was active in forming the 
complex EA-huC'~. The significance of quantitative difference in  activities  of 
euglobulin  fractions, tested at different times with different lots of EA, has 
not been investigated. 
C'1 activity as measured in the cold phase of the Donath-Landsteiner reaction: 
The  Donath-Landsteiner reaction  requires  the  presence  of  components  of 990  FIRST COMPONENT  OF HUMAN  COMPLEMENT 
complement in the initial cold phase of the reaction as well as in the second or 
warm phase. Previous studies indicated that C'1 reacts with cells and antibody 
in the initial phase  (31). The euglobulin fraction was therefore tested for its 
ability to complete the cold phase. 
Serial dilutions of euglobulin  (0.10 ml) were assayed as usual in the Donath- 
Landsteiner reaction, employing heated serum as a source of PCH antibody. 
The results, plotted in Fig.  1, demonstrated that the euglobulin fraction was 
a  satisfactory source of C'1, as measured by this parameter of Ctl  activity. 
C.  Properties of Euglobulin Fraction as a Source of Ct l  Esterase.--When  the 
euglobulin fraction was recalcified  to a final concentration of 10-*~ CaCk and 
incubated  at  37°C,  C'I  esterase  activity was  generated  and  hemolytic  Cq 
activity disappeared  (double dilution  assay with  R1)  at  parallel  and  rapid 
rates.  For example,  a  euglobulin fraction  containing  20,000 units of C'l/ml 
was recalcified  and diluted 1/3 in TBS buffer.  Cq activity completely disap- 
peared  and  maximal  generation  of  C'I  esterase  (180  units/ml  of undiluted 
euglobulin)  occurred during incubation at 37°C for 10 minutes and was unaf- 
fected by further incubation. Both reactions were approximately half maximal 
at 5 minutes. Thus,  with respect to these properties,  the euglobulin fraction 
of Cq behaved in a manner qualitatively similar  to that described previously 
(13) for a somewhat more purified  preparation. 
D.  Summary  of Properties of Euglobulin  Fraction as a  Source of C'l.--The 
preparation  of euglobulin met the following  criteria  for C'I  activity:  (a)  re- 
constitution  of the hemolytic activity of R1;  (b)  formation  of the  complex 
EA-huCq,4  from EA-huC4;  (c) direct formation of the complex EA-huC'I;  (d) 
completion  of the  cold phase  of the  Donath-Landsteiner  reaction;  and  (e) 
generation of Cq esterase during incubation at physiologic conditions of pH 
and ionic strength. On the basis of these criteria,  the euglobulin fraction repre- 
sented a satisfactory source of C'I  for further fractionation by column chro- 
matography. 
H.  Chromatographic Resolution of the Euglobulin Fraction into Three 
Activities of C'  I 
A.  Column  Chromatography  on  DEAE  Cdlulose.--Chromatography  was  performed  at 
5°C.  Twenty ml of human serum euglobulin fraction, concentrated  10-fold  with respect to 
serum, was allowed to drain into a  packed, equilibrated, DEAE cellulose column. Residual 
protein was flushed into the column with several 2 ml aliquots of cold starting buffer (pH 7.4 
phosphate, ionic strength 0.15,  containing 1 X  10  --8 •  Na3HEDTA)  and cold starting buffer 
was allowed to flow through the column. The effluent was collected in 10 ml aliquots on a 
volumetric fraction collector. A linearly increasing gradient of salt concentration at constant 
pH was run into the column after 100 to 150 ml had been collected. The gradient was produced 
by allowing 1000 ml of limit buffer (0.5  M NaC1 in starting buffer, 1 X  10-* M Na~HEDTA 
final concentration) in a liter Erlenmeyer flask to flow through a capillary tube into an identical 
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first flask, and thence into the column. The mixing flask was stirred magnetically. Usually 115 
to 125 aliquots were collected at a flow rate of 30 ml/hour under gravity flow. The protein 
content of each tube was estimated by measuring the absorption at 280 m/~ in a Zeiss spectro- 
photometer,  care being taken to expose each fraction to room temperature  as briefly as possi- 
ble. Graphic plots were made of fraction number vs. protein eluted, expressed as optical density 
at 280  m/~. 
Over  twenty  chromatographic  separations  were  performed  under  these 
conditions, using two different lots of DEAE cellulose, each of the same type 
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FIG. 2. Chromatographic  resolution of C'I activiW of euglobulin fraction  into three  ac- 
tivities: formation of F-,A-huCrl. 4 from EA-huC'4;  , protein eluted; -- --, ionic strength 
of elutrient;  cross-hatched  areas,  C~I activities.  The arrow  indicates  the start  of the salt 
gradient. 
and with the same exchange capacity. The euglobulin preparations were made 
from six different  pools O  f  normal human serum.  Although minor differences 
were  observed  in  the  protein  elution  patterns  in  these  experiments  (for  ex- 
ample,  compare Figs.  2  and 3),  the separation  and positions  of the activities 
to  be  described  were  remarkably similar.  Protein  recovery from the  column 
was approximately 80 per cent. 
B.  Properties  of  tke  Chromatographic  Fractions  in  Hemolytic  Systems.-- 
Preliminary  experiments  witk RI:  Individual  column  fractions,  recalcified 
with 5  X  10--~ excess of CaCI~, were tested initially for Ctl activity by serial 
dilution assay with R1. Significant amounts of C~I were not detected, a finding 
not attributable,  by direct measurement,  to generation of Ctl esterase during 992  :FIRST  COMPONENT  OF  HUMAN  COMPLEMENT 
chromatography.  Two  additional  possibilities  were  entertained:  either  C'I 
activity had been inactivated during fractionation or C~I  had been resolved 
into more than one chromatographic species. In order to test the latter possi- 
bility, various combinations of chromatographic fractions were tested for their 
hemolytic activity with R1. Referring to Fig. 3 as a typical chromatogram, it 
was found that addition to R1 of small amounts of a fraction in the region of 
tube 60 (0.05  ml of fraction q-  0.15 ml of R1) permitted the measurement of 
some CII activity in the region of tube 100. However, the reagent itself (frac- 
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FIG.  3.  Chromatographic resolution of C'1 activity of euglobulin fraction into three ac 
tivities: formation of EA-huC'I;  , protein eluted; -- --, ionic strength of elutrient 
cross-hatched areas, Crl activities. The arrow indicates the start of the salt gradient. 
tion 60 +  R1) was usually 5 to 20 per cent hemolytic and complete hemolysis 
of EA could not be achieved even with high concentrations of fraction 100. 
Further  preliminary  experiments  indicated  the  possible  participation  of  an 
additional factor in the region of tube  12 for reconstitution of the hemolytic 
activity of R1. However, control levels of hemolysis with R1 to which fractions 
from two suspected areas of activity had been added (e.g. fractions 12 +  68) 
were  too  great  to  permit  rigorous  conclusions  to  be  drawn.  Nevertheless, 
these  studies  with  R1  suggested  that  failure  to  measure  C'I  in  individual 
column fractions was due to resolution of C'I  into more than one activity. The 
problem was therefore investigated further and  with greater precision by the 
use of intermediate  complexes of the immune hemolytic  system. 
C~1 activity as measured by formation  of the complex EA-huC'I,4:  Individual 
column fractions, recalcified with 5  X  lO--*M  excess of CaCI~, were  tested for LEPOW,  NAFF, TODD, PENSKY, AND HINZ, JR.  993 
Ctl by their ability to form the complex EA-huCtl.4 from EA-huC~4. The frac- 
tions  were  assayed  using  the  conditions  described  above  for  the  euglobulin 
fraction,  except  that the incubation  time for complex formation was  reduced 
to  10 minutes and was followed by washing with TBS-gelatin buffer at  37°C. 
Formation  of the  complex EA-huC'~,4 was  not  observed  with any individual 
fraction or combination of two fractions tested at dilutions of  1/100. However, 
combination  of fractions  from three  discrete  areas  of  the  chromatogram  re- 
sulted in formation of large amounts  of the complex EA-huC~I.4. Referring to 
Fig. 2, these areas were in the region of tubes 12, 68, and 106. 
The activity peaks shown were obtained  in the following fashion: pellets of the complex 
EA-huC~4  containing 5 X 10  a cells were suspended in 0.5 ml each of 1/200 dilutions of fractions 
12 and 68 and 0.5 ml of 1/400 dilutions of fractions from the remainder of the chromatogram. 
Formation of the complex EA-huC~I. 4 was first detected with fraction 104, was maximal with 
fraction  106, and was no longer detectable with fraction  115. The quantitative results of this 
experiment are plotted in Fig. 2 as the activity peak on the far right, corresponding to a pro- 
tein peak eluted at ionic strength  0.37. 
In a similar fashion, the activity peak shown in the center of Fig. 2, was obtained  by re- 
peating  this  type of experiment  using  1/200 dilutions  of fractions  12 and  106 with 1/400 
dilutions of fractions from the remainder of the chromatogram.  Detectable  activity was con- 
fined to the region between tubes 55 and 80 with maximal activity at tube 68. This corres- 
ponded to a chromatographic species eluted at ionic strength 0.27. 
Finally,  the activity peak shown on the left of Fig. 2 was obtained using 1/200 dilutions 
of fractions 68 and 106 and 1/400 dilutions of fractions from the remainder of the chromato- 
gram. Activity was maximal with fraction 12, corresponding to the protein peak of the pregra- 
dient  fraction not adsorbed to DEAE cellulose at ionic strength 0.15. Although  most of the 
activity was confined to the pregradient  peak,  small amounts were  detectable  in  fractions 
eluted  at ionic strength  0.15 to 0.20. 
Combination  of fractions  68  and  106  at  1/200  dilutions  did  not  result  in 
most  instances  in  significant  formation  of  the complex  EA-huC'I,4;  that is, 
levels of hemolysis (O.D.,  541 m/~)  were in the range of 0.020 to 0.030,  to be 
compared  with  0.010  to  0.020  for the EA-huC'4 complex itself.  However,  it 
was an inconstant  finding that  such combinations  sometimes yielded  greater 
hemolysis, even when using the same fractions and same preparation  of EA- 
huC'4 complex.  Employing 1/100  dilutions of fractions 68  and  106,  levels  of 
hemolysis as high as 0.145 have been observed, to be compared with  1.10 for 
combinations  of fractions  12,  68,  and  106  at  1/100  dilutions.  An  adequate 
explanation of the inconstancy of this observation is not available at the present 
time. 
These experiments demonstrated that the C'1 activity present in the euglobu- 
lin fraction necessary for formation of the complex EA-huC'I,4 from EA-huC~4 
could be  chromatographically resolved  into  at least  three  separate  activities. 
For purposes of description,  these activities will be designated C'lq, C'lr, and 
C'ls in the order of their elution from DEAE cellulose. 994  ~FIRST  COM.PONENX  OF  HUMAN  COMPLEMENT 
C'  I  activity as measured by the complex EA-huC'x:  Recognition  of the multiple 
nature of C'I led to uncertainties concerning the actual state of the complex 
EA-huC'4. It will be recalled that this complex is made by decay of the complex 
EA-huC'l,4a, followed by elution of C'I with Na~-I_EDTA.  Although C'4, but 
no other activities, could be measured on the resulting complex by conventional 
means, the possibility was considered that unrecognized components might be 
present. It was therefore of interest to attempt to form the complex EA-huC'x 
directly from EA and various fractions from the DEAE cellulose columns. 
The results  of such  experiments were completely analogous  to  those  just 
described for formation of the complex EA-huC'a,4.  Using the technique de- 
scribed above for formation  of the complex EA-huC'I by reaction of the euglobu- 
lin preparation with EA, fractions from three discrete areas of the chromat- 
ogram were again required. The activity peaks for C'lq, C'lr, and C'ls shown 
in Fig. 3 were obtained in the manner already described, except that the activity 
sought was tested at a dilution of 1/200 using 1/100 dilutions of the remaining 
two components. 
The lack of participation of C'4 in these reactions involving C'lq, C'lr, and 
C'ls  was  demonstrated by chromatographing a  euglobulin fraction prepared 
from R4.  C'lq,  C'lr, and C'ls activity peaks were present in the usual posi- 
tions and were active in forming the complex EA-huC'I, despite the complete 
absence of C~4. 
Parallel assays in which the same chromatographic fractions were used either 
for formation  of  the  complex EA-huC'I,4  or  the complex EA-huC'~ demon- 
strated an excellent correlation between these two methods of measurement of 
C'lq,  C'lr,  and  C'ls.  In each case,  the  three activities were present in the 
same  areas  of the  chromatogram and maximal  activities were found in  the 
same fractions. 
These  results  suggested  that  elufion  of  the  complex  EA-huC'~.4  with 
Na3HEDTA at 37°C resulted in removal from the cell of C'lq, C'lr, and C'ls 
activities.  Although both the EA-huC'x  and  EA-huC'I,4  assays  were equally 
valid for detection and measurement  of the three C'1  activities,  the former 
method appeared to be the procedure of choice. This conclusion was based on 
the  greater  technical  simplicity  of  the  EA-huC'x  assay and  the theoretical 
desirability  of  forming  intermediate  complexes  with  purified  defined  com- 
ponents. 
Accordingly, preliminary experiments  have been performed on the effect of concentration 
of two of the Ctl factors on measurement of the third factor in the EA-huC', assay. For this 
purpose, it was first demonstrated that centrifugation and washing of the complex  EA-huC'a 
was not necessary.  The same levels of hemolysis  were obtained when human serum diluted in 
Na~MgEDTA buffer was added either to the washed complex  or directly to the reaction mix- 
ture of EA and C'lq, Cqr, and C'ls. In the latter case, after formation of the complex  EA- 
huC'l at 37°C for 10 minutes, 2.5 ml of 1/62.5 human serum in buffer containing 25.6 X LEPOW,  NAF~,  TODD, PENSKY,  AND  HINZ,  JR.  995 
10  4  M Na~MgEDTA were added (1/100 serum, 16 X  10  4  M Na~MgEDTA, final concentra- 
tions) and incubation was continued at 32°C for 60 minutes. 
Using this modified assay procedure,  each of the C'I components was titered 
in the presence  of 1/20,  1/50,  1/100,  and  1/200  dilutions of the remaining 
two C'1 components.  In general,  little difference was noted in the sensitivity 
of measurement of any one component using either 1/50 or 1/100 dilutions of 
the missing components. Diminution of activity was found at lower and higher 
concentrations.  In  all  cases,  high  concentrations  of  the  component  being 
TABLE I 
Measurement  of C'ls: Effect of Concentration of C'lq and C'lr on Formation of the 
Complex EA-kuCx 
Dilution of C'ls 
1/2o 
i/4o 
i/8o 
1116o 
11320 
1164o 
111280 
1/2560 
o 
1/2o 
O,O.* 
0.457 
0.501 
0.588 
0.442 
0.249 
0.093 
0.043 
0.018 
0.007 
Dilution of C'lq and C'lr 
1/50  1/lo0 
O.D.*  O.D.* 
0.561  0.589 
0.639  0.619 
0.667  0.637 
0.634  0.646 
0.449  O. 547 
0.214  0.327 
O. 100  O. 125 
0.035  0.049 
O. 007  O. 007 
1/200 
O.D.* 
0.537 
0.552 
O. 530 
0.434 
0.213 
0.092 
0.017 
0.010 
* Optical density at 541 m/z, corrected for EA control. 
titered were  inhibitory. The data in Table  I  for measurement of Cqs  are 
similar to those obtained for analogous measurements of C'lq and C'lr. 
These experiments,  which provide a basis for assay of Cqq, Cqr, and Cqs, 
demonstrated very dearly a synergistic effect of these components in formation 
of the complex EA-huC~I. For example, referring to Table I, 1/50 dilutions of 
Cqq and Cqr were inactive in the absence of Cqs, while significant formation 
of the complex EA-huCq could be achieved by the addition of a  dilution of 
1 per cent at 280 m/z,  1/640  of Cqs. Assuming  for Cqs a  value of 10 for E 1 cm 
this would correspond  to 0.15/~g of protein in the assay system. 
It was pointed out in the section on the role of Cqq, Cqr, and Cqs in the 
formation of the complex EA-huCq.4 from EA-huC', that significant levels of 
lysis with Cqr and Cqs in the absence of C'lq were occasionally  observed. 
This phenomenon has also been noted, again only with respect to C'lr and C'ls, 
in formation of the complex EA-huC'I, but the occurrence was related to the 996  FIRST  COMPONENT  OF  HUMAN  COMPLEM~ENT 
method of preparation of EA. If EA made with heated anti-Forssman rabbit 
serum was washed twice with an equal volume of TBS-gelatin buffer,  Cqr 
and Cqs  were completely and consistently inactive in forming the complex 
EAhuCtl, unless a source of Cqq was added. 
C~1 activity  as measured in the cold phase of the Donath-Landsteiner reaction: 
Cqq, Cqr, and Cqs were tested individually and in various combinations for 
their ability to complete the initial or cold phase of the Donath-Landsteiner 
reaction. As indicated in Table II, the fractions individually or in combina- 
tions of two were inactive, while combination of all three factors restored Ctl 
TABLE II 
Participation of C'  lq, C'  lr, and C'  ls in the Cold Phase of the Donath-Landsteiner 
Reaction 
C'lq 
ml 
0.10 
0.10 
0.10 
0.10 
Fractions in cold phase 
C'lr 
ml 
0.10 
0.10 
0.10 
0.10 
C'Is 
m/ 
0.10 
0.10 
0.10 
0.10 
Completion  of  cold  phase 
Hemolysis with RI 
O.D., 541 m# 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.450 
activity. At higher levels of antibody, a small amount of hemolysis occurred in 
the presence of Crlr and C~ls, in the absence of C/lq. 
In  contrast  to  the  hemolytic systems  described  above,  the  activities  of 
Cqr and C'ls could be diluted out more rapidly than Cqq.  This was deter- 
mined by serial dilution of each of the components individually while main- 
taining the  other  two at  constant high levels.  Half-maximal hemolysis was 
obtained at a  dilution of 1/64 with C'lq,  1/6 with  Cqr,  and 1/4 with Cqs. 
The markedly diminished sensitivity of this immune human hemolytic system 
in comparison with the hemolytic systems described above is apparent. 
C.  Properties  of Chromatographic  Fractions  as  a  Source  of  C1  Esterase.-- 
Individual chromatographic fractions, reealcified and adjusted to ionic strength 
0.15  by dilution, were  tested for their ability to  generate  Cq  esterase.  No 
single fraction or any combination of two fractions was  capable  of forming 
Cq  esterase  during  incubation  at  37°C  for  90  minutes.  However,  reaction 
mixtures containing Cqq,  Cqr,  and Cqs generated relatively large amounts 
of this enzyme under these conditions. The activity of C'lq,  Cqr,  and C~ls LEPOW)  NA.F1  ~)  TODD) PENSKY)  AND  ]~.=NZ) JR.  997 
with respect to activation of C~I  esterase is  shown in  Fig.  4.  The chromat- 
ogram is the same as Fig. 3. Activity peaks were obtained in a  manner con- 
ceptually analogous to that described for the measurement of these components 
in hemolytic systems. 
For example, the C'lq activity peak was obtained as follows: C'ls (pool of fractions 98 to 
101) was adjusted to ionic strength 0.15 by diluting 1/2.45 with distilled water and sufficient 
M/80CaCls to give a free Ca  ++ concentration of 10  -~ ~¢. Cqr (pool of fractions 59 to 63) was 
similarly adjusted with a  dilution of  1/1.86.  Fractions to be tested for Cqq  activity were 
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FIG.  4.  Chromatographic resolution of Ctl activity of eugiobulin fraction into three ac- 
tivities: generation of C~I  esterase;  , protein eluted; -- --, ionic strength of elutrient; 
cross-hatched areas, C~1 activities. The arrow indicates the start of the salt gradient. Chroma- 
togram same as shown in Fig. 3. 
diluted as necessary to achieve ionic strength 0.15 and 10  -~ M Ca  ++. The reaction mixtures 
then consisted of 1.0 ml of C'Is, 0.50 ml of C'lr,  and  0.50 ml of the fraction to be tested 
for C'lq activity. After incubation at 37°C for 30 minutes, 0.375 ml of pH 7.4 phosphate buffer, 
ionic strength 1.07, was added and the mixtures cooled in ice. By raising the ionic strength to 
0.3 in this manner and by lowering the temperature, further activation of C'I was retarded 
(13). The additional buffer also was necessary to permit accurate measurement of Cq esterase 
by esterolysis. The entire 2.375 ml of reaction mixture was then assayed by addition at 37°C 
of 0.125 ml of 1 M N-acetyl-r.-tyrosine ethyl ester in methyl cellosolve and performing micro- 
formol titrations with 0.05 N NaOH on 1.0 ml aliquots removed at 0 and 15 minutes. The re- 
sults are expressed as units of CI1 esterase per 1.0 ml aliquot, where 1 unit corresponds to the 
liberation of 0.5 micromole of H + (32, 33). 
Generation of C'I esterase occurred only when fractions from the pregradient protein peak 
were added  to Cqr and CZls.  The activity peak shown on the left of Fig. 4  corresponded 
to the C'lq peak shownin Fig. 3 for EA-huC'I formation with the identical fractions. 
The C'lr peak in the enzyme activation assay was obtained by incubating 1.0 ml of Cqs, 998  ]~IRST COM2PONENT 0]~ HUMAN COMPLEMENT 
0.50 ml of C'lq (pool of fractions 13 to 15), and 0.50 ml of the remaining fractions of the 
ehromatogram under the conditions  already described. Finally C'ls was measured in the en- 
zyme activation assay by incubating 0.50 ml of C'lq, 0.50 ml of C'lr, and 1.0 ml of the frac- 
tion to be tested for C'ls activity under the same conditions. As in the case of Cqq, there 
was excellent  correlation  between C'lr and C~ls as measured either in the esterolytic  or hemo- 
lytic assays (compare  Figures 2, 3, and 4). 
Enzyme generation occurred as  a  function of time at 37°C  and was  half- 
maximal  at  8  minutes  and  essentially  complete at  15  minutes,  using  peak 
fractions of C'lq,  C'lr,  and  C'ls.  Activation was not inhibited by soy bean 
trypsin inhibitor at a  final concentration of 5 mg/ml. 
D.  Summary of Properties of Chromatographic Fractions as a Source of C'I.-- 
Chromatography of the euglobulin fraction resulted in the resolution of C'I 
activity into  three discrete activities, designated  C'lq,  C'lr,  and  C'ls.  The 
participation of all three of these factors for reconstitution of C'I activity was 
demonstrated  by  their  requirement for:  (a)  formation of  the  complex EA- 
huC~x.4 from  EA-huCt4;  (b)  direct  formation of  the  complex EA-huC~I;  (c) 
completion of  the  cold phase  of  the  Donath-Landsteiner  reaction;  and  (d) 
generation of C~I  esterase during incubation at  37°C. 
III.  Identification of tke  Tkree  Ckromatographic Activities of Ctl 
Before investigating  the  possible  relationship  of  C~lq,  C'lr,  and  Ctls  to 
known  components of  complement,  the  possibility was  considered that  one 
or  more  of  these  activities  was  an  expression of  antibody  to  erythrocytes. 
However, absorption of each fraction with an equal volume of washed, packed 
sheep erythrocytes at I°C for 1 hour did not result in significant loss of activity 
in formation of the complex EA-huC'I. 
A.  Identity of C~lq with llS Component.--When individual chromatographic 
fractions were assayed for 11S component by the method of Mfiller-Eberhard 
and  Kunkel  (8),  large  amounts  were  found  in  the  pregradient  area  of  the 
chromatogram.  3 Fig. 5 shows the correlation between concentrations of protein 
and of 11S component in the fractions emerging from the column before and 
immediately after gradient elution. The distribution of 11S component closely 
paralleled the distribution of C~lq activity as measured with the same frac- 
tions in hemolytic systems and in the enzyme activation assay. This correlation 
is illustrated by comparing Fig. 5 with the corresponding area of Figs. 2 to 4. 
The possible identity of C'lq with 11S component was further investigated 
by testing the activity of purified llS component as a  substitute for C'lq in 
hemolytic and enzymatic assays for C'1. In all cases, the C'1 activity of mix- 
tures  of  C'lr  and  C'ls  was  reconstituted by addition  of purified  llS  com- 
ponent.  The  level  of  activity was  comparable  to  that  achieved with  C'lq 
3  This observation was first made by Dr. Floyd Green in this laboratory in 1961. LEPOW,  NA.FF, TODD, PENSKY, AND  HINZ,  .JR.  999 
fractions  containing  corresponding  concentrations  of  llS  component,  as 
measured with EA and RllS  (8). This conclusion  is illustrated in Fig. 6 for 
formation of the complex EA-huC'I,4  from EA-huCt4  and is representative of 
analogous data for formation of the complex EA-huCtl,  for completion of the 
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FIo. 5. Identification of C'lq with llS component: A, IlS component activity; O, protein 
eluted in the pre- and imm~iatdy postgradient area of the chromatogram. 
cold phase  of  the  Donath-Landsteiner  reaction,  and  for  generation  of  C'I 
esterase. 
Final proof of the identity of the llS component with C~lq and its lack of 
identity with C~lr and  C'ls was provided by experiments with a  euglobulin 
prepared  from  RllS.  Chromatographic  separation  of  this  preparation  was 
performed under the same conditions used for euglobulin fractions from normal 
human serum. The pregradient fractions from euglobulin devoid of llS com- 
ponent activity were also devoid of C~lq activity as measured by formation 
of the complexes EA-huCrl and EA-huCIx.4 and by generation of C~I esterase. 1000  ~IRST  COMPONEI~T  O~  HUMAN  CO~/PLEMENT 
Nevertheless, C'lr and C'ls activities were present in their usual positions on 
the chromatogram.  Data  supporting  these  conclusions are presented in  Ta- 
ble III. 
B.  C'lr  as  a  New Component  of Complement.--Chromatographic  fractions 
of euglobulin prepared from serum were examined for the presence of other 
components  of  complement.  Significant  C'2  activity  was  not  found  in  the 
euglobulin  fraction  and  was  therefore not  sought  in  column  fractions.  As 
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Fio. 6. Identification of C'lq with llS component: formation of EA-huC'I. 4 from EA- 
huC'4, using C'ir, C'ls, and chromatographically  separated C'lq, O; C'lr, C'ls, and 11S 
component purified with aggregated gamma globulin, A. 
shown in Fig. 7, C'3a activity was eluted from the column at a slightly lower 
ionic strength than  C'lr.  The C'3a peak was obtained by suspending pellets 
of the complex EA-huC'l.,a  (5  X  108 cells) in 4.0 ml of  1/4000  dilutions of 
fresh guinea pig serum, containing 8  X  10-8M Na3HEDTA, and 0.1 ml of the 
fraction to be  tested.  The mixtures were incubated at  32°C  for 60 minutes 
and the extent of hemolysis determined as usual (29). Small amounts of total 
C'3 activity could also be detected in the same region of the chromatogram, 
as measured by restoration of the hemolytic activity of R3. 
C'4 activity was eluted from the column at a  slightly higher ionic strength 
than  C'lr  (Fig.  7). The C'4 peak was obtained by serial dilution assay with 
EA and R4. In order to increase the sensitivity of detecting C'4, a  source of 
C'3a was added to R4 (0.1  ml of R4 -J- 0.1 ml of recalcified pool of fractions LEPOW,  NA.FF,  TODD,  PENSKY~ AND  HINZ,  JR.  I001 
51 and 52 to each assay tube). The concentrations of C'4 shown in Fig.  7 are 
therefore artificially magnified. 
It was dear from these experiments  that C'lr could not be related to C'2, 
C'3, or C'4.  Furthermore, its participation in reactions requiring C'1  served 
to define C'lr as part of the activity classically ascribed to C'1. It had already 
TABLE  III 
Comparison of Activities of Chromatographic  Fractions of Euglobulin Prepared from 
Normal Human Serum and RllS 
C'lq 
Serum 
RllS 
Serum 
Serum 
Serum 
RllS 
llS component 
Source of fraction 
C'lr 
Serum 
Serum 
RllS 
Serum 
R11S 
RllS 
RllS 
C'Is 
Serum 
Serum 
Serum 
RllS 
RllS 
RllS 
RllS 
Formation of complex* 
EA-huCq  EA-huC'I,4 
O.D., 541 rala  O.D.,  541 m~ 
0.650  1.00 
0.000 
O. 520 
0.630 
0.680  1.04 
0.000  0.000 
O. 580  O. 950 
Generation of 
C'l-esterase1: 
uni~s/ml 
17.0 
0 
16.1 
7.7§ 
7.7§ 
0 
* Complexes were formed as described previously using pellets of EA or EA-huC'4 (5 X 
10a/ml) and 0.5 ml each of C'lq, C'lr, and C'ls at dilutions of 1/100 for fractions derived 
from normal serum and 1/10 for fractions derived from RllS. The latter high concentration 
was selected to compensate for the dilution incurred as a result of chromatographing 1/4 the 
usual amount of euglobulin on a  standard size column. Purified 11S component was substi- 
tuted for C'lq, using 0.5 ml of a dilution containing 0.04 unit/ml. 
Pools of fractions from the C'lq, C'lr, and C'ls areas of the R11S-euglobulin chromato- 
gram only were lyophilized, concentrated 3-fold with respect to the original column fractions, 
dialyzed vs.  rIBS buffer at  1°C,  and used for assay of C'1 esterase generation as described 
previously.  Corresponding  fractions  from  the  normal  euglobulin  were  adjusted  to  ionic 
strength 0.15 by dilution and used without further concentration. 
§ C'ls was concentrated an additional 4-fold by dialysis vs.  carbowax in order to obtain 
these significant levels of C'1 esterase activity. 
been  shown that C'lq was identical with the 11S  component and it will be 
shown below that C'ls is probably identical with C'1 proesterase.  On the basis 
of these considerations,  C'lr is proposed  as a new component of complement. 
C. Identity of C'ls with C'1 Proesterase.--Incubation  of euglobulln at 37°C 
for  15  minutes in the absence  of Na~_EDTA results in generation of C'1 
esterase.  When such euglobulin  is chromatographed under conditions  similar 
to those described above, Cq esterase  activity is found in fractions eluted at 
ionic  strength 0.37 (34). It will be recalled  that C'ls is also  eluted at this 
ionic  strength.  The  close  correspondence  of  chromatographic  behavior  of 
C'I esterase and Cqs was confirmed by performing separations,  under identical 1002  I~IRST COMIPONENT OF HUMAN  COMPLEMENT 
chromatographic conditions, of a  single euglobulin fraction, half of which had 
been activated to C'I esterase. C'I esterase and C'ls were again eluted at ionic 
strength 0.37.  Since C'ls had no esterolytic activity until  reacted with  C'lq 
and  C'lr and  since  C'ls and  C'I esterase were chromatographically related, 
C'ls was identified as C'I proesterase. This conclusion has been confirmed by 
the  antigenic similarity between  C'ls and  C'I esterase,  demonstrable by gd 
diffusion and immunoelectrophoretic analyses with  rabbit  antisera to human 
C'1 esterase (35). 
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FIG. 7. Lack of identity of C'lr with C'3a and C'4: 
0.50 
4~ 
/  0.40 
0.30 ~:~ 
o.£o 
0.10 
, protein eluted; -- I, ionic strength 
of elutrient. The arrow indicates the start of the salt gradient. Chromatogram same as shown 
in Figs. 3  and 4. 
DISCUSSION 
The  experiments  reported  in  this  paper  have  shown  that  the  first  com- 
ponent of human complement, an activity previously assumed to be a  single 
substance, may be chromatographically resolved into three separate activities. 
It is of interest to examine earlier attempts at purification of C'I in terms of 
lack of recognition of the multiple nature of this component. 
Pillemer and coworkers  (36, 37)  obtained preparations of guinea pig and human 
C'I which  were  relatively highly purified  on the basis of electrophoretic and ultra- 
centrifugal criteria.  However, more precise methods for the measurement of C'I were 
not then available. The assay employed depended upon reconstitution of the hemolytic 
activity of R1 with a volume of purified fraction equivalent to 1 hemolytic unit in the 
original  serum. Using this method, complete hemolysis was usually achieved,  but no 
information is available on the extent to which the fractions could be further diluted LEPOW~ NA~F~ TODD~ PENSKY, AND HINZ~ JR.  1003 
and  still  retain  hemolytic activity.  This  point is  of particular  importance  since  a 
recovery of C"I of only a few per cent would suffice to give complete hemolysis, when 
tested in the manner described. Indeed, human C'1 recently prepared by the method 
of Pillemer, Seifter, San Clemente, and Ecker (37)  restored hemolytic activity to R1 
when the fraction was tested at high concentration. However, the yield obtained in 
this single trial was less than 1 per cent, as determined by serial dilution assay with 
R1. The final fraction (1BD) was active at high concentration in forming the complex 
EA-huC'I and contained small amounts of C'lq,  C'lr, and C'ls. A  discard fraction 
(1BB) was particularly rich in C'lq (11S component). Thus, the C'1 preparation of 
Pillemer and coworkers probably represented  a  mixture,  in low yield,  of the  three 
activities of C'1 described in this report. 
A  preparation  of  partially  purified  human  C'I  previously  described  from  this 
laboratory (14)  was highly active as a source of C'1 in various immune  systems (13, 
31, 38-40). However, this fraction was only 30- to 50-fold  purified with  respect to 
serum and contained at least three electrophoretic  and ultracentrifugal components. 
Attempted further purification resulted in large apparent losses of activity, a phenom- 
enon probably referable to the resolution of C'1 into separate activities. 
Although considerable progress has been made in the chromatographic separation 
of other components of complement (12, 41, 42), only one method has been described 
for purification of C'1 by this technique (12, 26). It is noteworthy, however, that the 
fraction of guinea pig C'1 so obtained contained approximately 45 percent of the serum 
protein.  Thus,  previous failures  to  demonstrate  the  multiple  nature  of  C'1  would 
appear to have been due to the methods of assay employed and to inadequate degrees 
of purification. 
The three  activities of human  C'I described in this paper have been designated 
C'Iq, C'lr, and C'ls, in the order of their elution from DEAE cellulose. 4 C'lq was 
demonstrated to be identical with the  11S component (8-10), thus establishing this 
component as part of the activity previously ascribed to C'1. It was not possible to 
relate  C'lr  to  a  known  component of  complement.  These  studies  have  therefore 
provided  evidence  for  the  existence  of  a  previously  unrecognized  component  of 
complement. On the basis of chromatographic data,  C'ls was identified as  C'I pro- 
esterase. It has been shown that C'lq, C'Âr, and C'ls all participate in various hemo- 
lyric reactions requiring C'1. For example, the complex EA-huC'I could be formed by 
interaction of the sensitized erythrocyte (EA) with small concentrations of each of the 
three  C'1  activities.  Such  experiments,  in which  relatively  purified  fractions  were 
used and in which the role of 11S  component was recognized, stand  in contrast to 
previous studies on formation of the complex EAC'I (23, 25-27). 
C'lq, C'lr, and C'ls could each be measured by serial dilution of one of the activities 
in the presence of a  constant amount of the remaining  two. This has been demon- 
strated in formation of the complex EA-huC'I.4 from EA-huC'4 and formation of the 
4 This nomenclature  has been provisionally adopted  as a means of referring to the three 
activities of human C'1 which have been recognized in this investigation. The series.., q, r, 
s... was selected to avoid any connotation  of function until  such functions are definitively 
established.  The series a,  b, c... was contraindicated  because of previous use of C'la for 
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complex EA-huC~I. It has also been shown for completion of the cold phase of the 
Donath-Landsteiner reaction, employing human erythrocytes and human antibody 
from patients with paroxysmal cold hemoglobinuria.  Of these, formation of the com- 
plex EA-huCtl offers  the  theoretical and practical advantages of permitting direct 
interaction of a readily available, defined antigen-antibody complex (EA)  with puri- 
fied components. The sensitivity of the EA-huCtl assay may be illustrated by com- 
paring the detection of llS component (C~lq) in this system and in the RllS assay 
described  by Miiller-Eberhard and Kunkel (8). The lower limit of sensitivity of the 
latter assay is 1 unit/ml~ using the definition of 1 unit described above, whereas in the 
former assay concentrations less than 0.01 unit/ml may be measured. 
In all of the hemolytic systems investigated, the observation has been made that 
mixtures of C~lr and Ctls occasionally  functioned to a limited extent in the absence 
of a known source of C'lq. The possibilities have been recognized that this may have 
been due  to contamination of C~lr with Ctlq,  or to the presence of  C~lq  derived 
from rabbit hemolysin. Since  C~lr  and  C~ls were inactive in forming the complex 
EA-huCtl when EA suspensions were first washed with TBS-gelatin buffer, the former 
possibility becomes improbable and the latter more plausible.  Investigations on the 
possible  presence of functionally active C~lq in heated anti-Forssman rabbit serum 
and an adequate explanation of this phenomenon are in progress (43).  In this con- 
nection it is emphasized that although C'lq, C~lr, and Cels have all been shown to 
participate in reactions requiring C~I, no definitive  conclusions  can be drawn at this 
time concerning  their absolute requirement. 
It is of particular interest that C~lq, C~lr, and C~ls participated not only in hemo- 
lytic reactions requiring  C~I but were  also  involved in  generation of Ctl  esterase. 
Activation of this enzyme could be effected  when all three of these activities were 
incubated  together  under  suitable  conditions  of  concentration,  temperature,  pH 
and ionic strength. Thus, the reaction of EA with C~lq, C~lr, and C'ls to form the 
complex EA-huCr~ was correlated with generation of C~I esterase by interaction of 
the  three  components of  Ctl  in  the  absence of  antigen-antibody complexes.  Bio- 
chemical events occurring in the presence of the erythrocyte-antibody complex could, 
therefore, be duplicated and examined in free solution.  This observation provides an 
important tool for further studies  on the  mechanism of initiation  and on possible 
methods of inhibition of complement action. Definition of the sequence  of action of 
C~lq, C~lr, and Ctls, prerequisite to such studies, has not yet been achieved, although 
the hypothesis has already been advanced by Mtiller-Eberhard  and Kunkel  (8,  9) 
and by Hinz and Mollner  (44) that  C'lq (llS  component) may be the  first com- 
ponent to function. 
A  framework is now available for assembling biochemical events from first 
reaction of an antigen-antibody complex with a  component of C'I up to and 
including  formation of the complex EAC~I.4.s  (Table IV).  Interaction of the 
immune complex and the three components of Ctl results in formation of the 
complex EACPl and generation of C~I esterase. This enzyme in turn reacts with 
C~4 in  a  manner  which  is  still  biochemically undefined  but  which  is  almost 
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interacts  with  C'2  (14).  The  functional  integrity  of the  enzyme is required 
for formation of the complex EACh1.4,, from EAC'I,4  and C'2  (40, 45). Recent 
observations further suggest that C'2 is enzymatically cleaved by C'I esterase 
(46) during formation of the complex EAC'I,4,~. Thus, the generation and sub- 
sequent action of C'I esterase appear to occupy central positions in the func- 
tion of C'I, C'4, and C'2. An analogous biochemical framework for the func- 
tioning of the components of C"3 has not yet emerged.  It is known, however, 
that  C'I  esterase is not involved in the C'3 steps  (40, 45)  and the terminal 
morphologic and physiopathologic events of immune cytolysis have been well 
described (47--49). 
TABLE IV 
Corrdation of Intermedgate Reavtions and Biockemir,  al Erents in Immune Hemolysis 
Reactants and intermediate  complexes  Biochemical  events 
EA Jr Cllq Jr C'Ir Jr C'Is  Ca+* > EAC'I 
EAC'I -'['-  C'4  'EAC',, 4 
EACI.., Jr C'2  Ms*+  ~EAC'.. ~. 2 
EAC'I.~a Jr  C'3a Jr  C'3b Jr  C'3c  ,E* 
E*  ,  ghost 
Jr hemoglobin 
Generation of C'I esterase 
Interaction  of  C'I  esterase  with  C'4; 
nature  of reaction unknown 
Interaction  of  C~I  esterase  with  C~2; 
enzymatic  cleavage  of  C~2; fulfill- 
ment of function of C'I esterase 
Unknown biochemical role of C'3 com- 
ponents,  resulting  in  production  of 
holes in  cell membrane,  loss  of per- 
meability control, and osmotic lysis 
SUMMARY 
A euglobulin fraction of human C'I has been chromatographically resolved 
into three distinct activities, designated C'lq,  C'lr, and C~ls, in the order of 
their elution from DEAE cellulose. All three of these activities have been shown 
to participate in various hemolytic reactions requiring C'I, including  the cold 
phase of the Donath-Landsteiner. reaction, and to be necessary for generation 
of C'I  esterase. C'lq was identical with a previously described serum protein 
implicated in a very early step of complement action and designated the llS 
component on the basis of its sedimentation constant. C~lr could not be related 
to a known complement activity and has been presented as a new component. 
Cqs, on the basis of chromatographic evidence, was identified with C~I proes- 
terase. Methods of assay of these components of C'I have been presented. 
The significance  of C'lq,  C'lr,  and  C'ls in generation  of C'I  esterase and 
the central role of this enzyme in reactions involving C'I,  C'4, and C'2 have 
been discussed. 1006  FIRST COMPONENT OF HUMAN COMPLEMENT 
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